TY - JOUR
T1 - Placental transfer and decay of varicella-zoster virus antibodies in preterm infants
AU - Linder, Nehama
AU - Waintraub, Ilana
AU - Smetana, Zehava
AU - Barzilai, Asher
AU - Lubin, Daniel
AU - Mendelson, Ella
AU - Sirota, Lea
PY - 2000/7
Y1 - 2000/7
N2 - Objectives: To compare the placental transfer of maternal varicella- zoster (VZV) antibodies to preterm and term infants and to investigate antibody decay during the first 6 months of life in the preterm infants. Study design: Maternal and umbilical cord blood samples were taken from 113 healthy mother-newborn pairs: 64 term (gestational age ≥37 weeks) and 49 preterm (gestational age ≤35 weeks). Premature infants were further tested at 1, 2, and 6 months. Anti-VZV antibody to membrane antigen was measured with the immunofluorescent technique. Results: Preterm infants of gestational age ≤28 weeks had positive cord antibody and a geometric mean titer significantly lower than those in preterm infants of gestational age 29 to 35 weeks and term infants (25% vs 95% and 95%, respectively, P <. 001 for each, and 2.5 ± 2.2 vs 10.5 ± 2.4 and 12.6 ± 2.4, respectively, P <. 001 for each). There was no difference between the preterm 29 to 35 weeks of gestation and term groups. Fetal-maternal ratios for both preterm groups were < 1 and were significantly less than the fetal-maternal ratio in the term infants. The transfer of maternal antibodies to term infants was significantly greater than to the 29- to 35-week preterm infants (P =. 01). At 2 months of age, 25% of 29- to 35-week preterm infants and no preterm infant ≤28 weeks had a positive titer. At 6 months of age, all preterm infants were seronegative, and the geometric mean titer in both groups declined to undetectable levels. Conclusion: Transplacental transfer of maternal VZV antibodies is diminished in preterm infants. VZV antibody levels are significantly lower in preterm infants born at ≤28 weeks' gestational age compared with those in preterm infants 29 to 35 weeks' gestational age and term infants. Anti-VZV titers decrease to undetectable levels in preterm infants by 6 months of age or earlier; thus these infants appear to be susceptible to chickenpox before the scheduled 12-month vaccination.
AB - Objectives: To compare the placental transfer of maternal varicella- zoster (VZV) antibodies to preterm and term infants and to investigate antibody decay during the first 6 months of life in the preterm infants. Study design: Maternal and umbilical cord blood samples were taken from 113 healthy mother-newborn pairs: 64 term (gestational age ≥37 weeks) and 49 preterm (gestational age ≤35 weeks). Premature infants were further tested at 1, 2, and 6 months. Anti-VZV antibody to membrane antigen was measured with the immunofluorescent technique. Results: Preterm infants of gestational age ≤28 weeks had positive cord antibody and a geometric mean titer significantly lower than those in preterm infants of gestational age 29 to 35 weeks and term infants (25% vs 95% and 95%, respectively, P <. 001 for each, and 2.5 ± 2.2 vs 10.5 ± 2.4 and 12.6 ± 2.4, respectively, P <. 001 for each). There was no difference between the preterm 29 to 35 weeks of gestation and term groups. Fetal-maternal ratios for both preterm groups were < 1 and were significantly less than the fetal-maternal ratio in the term infants. The transfer of maternal antibodies to term infants was significantly greater than to the 29- to 35-week preterm infants (P =. 01). At 2 months of age, 25% of 29- to 35-week preterm infants and no preterm infant ≤28 weeks had a positive titer. At 6 months of age, all preterm infants were seronegative, and the geometric mean titer in both groups declined to undetectable levels. Conclusion: Transplacental transfer of maternal VZV antibodies is diminished in preterm infants. VZV antibody levels are significantly lower in preterm infants born at ≤28 weeks' gestational age compared with those in preterm infants 29 to 35 weeks' gestational age and term infants. Anti-VZV titers decrease to undetectable levels in preterm infants by 6 months of age or earlier; thus these infants appear to be susceptible to chickenpox before the scheduled 12-month vaccination.
UR - http://www.scopus.com/inward/record.url?scp=0034235592&partnerID=8YFLogxK
U2 - 10.1067/mpd.2000.106902
DO - 10.1067/mpd.2000.106902
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0034235592
SN - 0022-3476
VL - 137
SP - 85
EP - 89
JO - Journal of Pediatrics
JF - Journal of Pediatrics
IS - 1
ER -